In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models.

scientific article

In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NUCMEDBIO.2013.04.012
P698PubMed publication ID23915801
P5875ResearchGate publication ID255691116

P50authorVojtěch KubíčekQ57391736
P2093author name stringFrank Rösch
Ralf Bergmann
Marco Fellner
Marian Meckel
Natalie Thieme
P433issue6
P304page(s)823-830
P577publication date2013-08-01
P1433published inNuclear Medicine and BiologyQ7067979
P1476titleIn vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models
P478volume40

Reverse relations

cites work (P2860)
Q38919414(177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment
Q38269216A nuclear chocolate box: the periodic table of nuclear medicine.
Q59468861Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid
Q38358666Continued rapid growth in (68) Ga applications: update 2013 to June 2014.
Q33807722Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
Q53066975Gallium(III) complexes of NOTA-bis (phosphonate) conjugates as PET radiotracers for bone imaging.
Q40098290New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
Q47165356Phosphonic acid: preparation and applications

Search more.